Archive · 17 Aug 2026
Godavari Biorefineries secures European patent for anti-cancer drug composition
A company in India called Godavari Biorefineries got a special award called a patent from Europe.
A patent is like a certificate that says, 'We invented this, and no one else can copy it without permission.'
The invention is a medicine recipe that helps fight cancer.
The recipe mixes special cancer-fighting ingredients with another ingredient that helps the body absorb them better.
This makes the medicine work better and be more useful.
The medicine could be used to treat breast cancer and prostate cancer.
It can be taken by mouth, which is easier for patients.
The company's scientists worked hard to make the medicine easier for the body to use.
The company's leaders say this is an important step in their research journey.
The company usually makes ethanol and bio-based chemicals, but now it is also working on healthcare solutions.
Godavari Biorefineries Limited secured a product and process patent from the European Patent Office for a pharmaceutical composition combining novel anti-cancer compounds with a solubilising agent.
The composition is designed to enhance the solubility and bioavailability of the active compounds, improving their therapeutic potential.
The patent has significant applications in treating cancers, including breast and prostate cancers, through oral administration.
The patent adds to Godavari Biorefineries Limited's oncology-focused intellectual property portfolio.
Godavari Biorefineries is the flagship company of the Somaiya Group, one of India's largest producers of ethanol and manufacturers of bio-based speciality chemicals.
- Who
- Godavari Biorefineries Limited, the flagship company of the Somaiya Group, led by Chairman and Managing Director Samir Somaiya and Executive Director Dr Sangeeta Srivastava.
- What
- Secured a product and process patent from the European Patent Office for a pharmaceutical composition combining novel anti-cancer compounds with a solubilising agent.
- When
- Announced in an article published on August 17, 2026.
- Where
- Granted by the European Patent Office in Europe.
- Why
- To enhance the solubility and bioavailability of anti-cancer compounds, improving their therapeutic potential for treating cancers including breast and prostate cancers.
- Company
- Godavari Biorefineries Limited
- Patent Office
- European Patent Office
- Patent Type
- Product and process patent
- Composition
- Novel anti-cancer compounds with a solubilising agent
- Applications
- Treating cancers including breast and prostate cancers via oral administration
- Parent Group
- Somaiya Group
- Key Executives
- Samir Somaiya (Chairman and Managing Director), Dr Sangeeta Srivastava (Executive Director)
- Company Profile
- One of India's largest producers of ethanol and manufacturers of bio-based speciality chemicals